An Observational Cohort Study to Evaluate the Safety and Efficacy of Micardis Tablets Taken Once Daily at 40 mg/Day and 80 mg/Day in Hypertensive Patients Under Real Life Conditions in Usual Clinical Practice

CompletedOBSERVATIONAL
Enrollment

987

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

August 31, 2008

Conditions
Hypertension
Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY